Whereas lower-depend MBL rarely progresses to CLL, high-depend MBL progresses to CLL necessitating therapy in a level of one% to two% every year. Higher-rely MBL is distinguished from Rai 0 CLL determined by whether the B-cell count is above or under 5 × 109/L. Although people with the two higher-depend MBL and CLL Rai phase 0 are at elevated dang